A boutique CRO for Central Europe

One partner. Three countries. One experienced team.

Phase I–IV clinical trials · medical device investigations · feasibility to close-out

Brillance attends BIO-Europe 2025 in Vienna


 

 

 

Brillance attended BIO-Europe 2025 in Vienna, where we built new connections and explored potential collaborations in the delivery of clinical trials.

 

Our CRO was represented on-site by Izabela Kozdraś-Urbanek, Chief Operating & Development Officer, who met with partners and prospective clients during numerous business discussions.

News

Brillance at COG: CRO Summit Europe 2026 in Amsterdam

 

Brillance at BIO International Convention 2026 in San Diego

Brillance attends BIO-Europe 2025 in Vienna

 

 

 

CRO Poland

Clinical Trials

Monitoring of Clinical Trials